Related scientific articles (all)

Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.

Authors : Lalami Y, Awada A
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(3)
Pages : 235-40

Prévention et traitement des infections. (TEXTBOOK : « Thérapeutique du cancer » Morère JF, Mornex F., Soulières D. 2ème édition. Springer-Verlag, Paris, France)

Authors : Klastersky J, Aoun M
Year : 2011
Journal : Book
Volume : -
Pages : 151-65

Supportive care for patients with gynaecological cancer

Authors : Klastersky J, Lossignol D
Year : 2011
Journal : South Afr Gynaecol Oncol
Volume : 3
Pages : 9-12

A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.

Authors : Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A
Year : 2011
Journal : Clin Cancer Res
Volume : 17(21)
Pages : 6897-6904

The Research Ethics Committee at Universidade Federal de Santa Maria: a brief historical review

Authors : Nardin Weis L, Hundertmarck Minato E, Borges Fagundes R, Bins di Napoli R, Emando Silva C, de Campos Velho MTA, Dal Lago L
Year : 2011
Journal : Revista HCPA
Volume : 31(3)
Pages : 372-76

Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

Authors : Aftimos P, Awada A
Year : 2011
Journal : Adv Ther
Volume : 28(11)
Pages : 973-85

A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough.

Authors : Toussaint E, Flamen P, Demetter P, Matos C, Van Gossum M, Delhaye M, Closset J, Loi P, Deviere J, Arvanitakis M
Year : 2011
Journal : Endoscopy
Volume : 43 Suppl 2 UCTN(null)
Pages : E221-2

Envelhecimento e doença crônica - editorial

Authors : Dal Lago L
Year : 2011
Journal : Revista da AMRIGS, Porto Allegre
Volume : 55(1)
Pages : 5-6p

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Authors : Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Sales F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G
Year : 2011
Journal : Br J Cancer
Volume : 105(11)
Pages : 1726-32

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Authors : Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I
Year : 2011
Journal : J. Nucl. Med.
Volume : 52(3)
Pages : 354-61

New development in hormone receptor-positive disease.

Authors : Piccart-Gebhart M
Year : 2011
Journal : Oncologist
Volume : 16 suppl 1
Pages : 40-50

HER2-positive circulating tumor cells in breast cancer.

Authors : Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : PLoS One
Volume : 6(1)
Pages : e15624

Outils génomiques pouvant aider au choix thérapeutique des cancers du sein – Analyse in « Cancer du Sein : compte-rendu du 12ème Cours francophone supérieur de cancérologie – (TEXTBOOK : Nice, St-Paul de Vence, Janvier 19-22, 2011 » Namer M., Héry M.

Authors : Ignatiadis M, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : 311-16

Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial.

Authors : Awada A, Gil T, Whenham N, Van Hamme J, Besse-Hammer T, Brendel E, Delesen H, Joosten MC, Lathia CD, Loembé BA, Piccart-Gebhart M, Hendlisz A
Year : 2011
Journal : J Clin Pharmacol
Volume : 51(12)
Pages : 1674-84

Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Authors : Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C
Year : 2011
Journal : Breast J
Volume : 17(4)
Pages : 343-51

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.

Authors : Loi S, Symmans WF, Barlett JM, Fumagalli D
Year : 2011
Journal : Lancet Oncol
Volume : 12 (12)
Pages : 1162-8

Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.

Authors : El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 80(3)
Pages : 433-49

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.

Authors : Rothé F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, Badran B, Fayyad-Kazan H, Desmedt C, Harris AL, Piccart-Gebhart M
Year : 2011
Journal : PLoS One
Volume : 6(6)
Pages : e20980

The EORTC 10041/BIG03-04 MINDACT trial is feasible : results of the pilot phase.

Authors : Rutgers E, Piccart-Gebhart M, Bogaerts J, Delaloge S, Veer LV, Rubio IT, Viale G, Thompson AM, Passalacqua R, Nitz U, Vindevoghel A, Pierga JY, Ravdin PM, Werutsky G, Cardoso F
Year : 2011
Journal : Eur J Cancer
Volume : 47(18)
Pages : 2742-9

Gene profiling assay and application: the predictive role in primary therapy.

Authors : Fumagalli D, Desmedt C, Ignatiadis M, Loi S, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pages : 124-7